70 related articles for article (PubMed ID: 17692456)
21. Monoclonal antibody to a human salivary gland adenocarcinoma cell line: augmentation of antibody-dependent cell-mediated cytotoxicity activity by streptococcal preparation OK-432 in human salivary gland adenocarcinoma-bearing nude mice given the antibody.
Kaji R; Yoshida H; Yanagawa T; Sato M
J Biol Response Mod; 1989 Oct; 8(5):488-500. PubMed ID: 2552025
[TBL] [Abstract][Full Text] [Related]
22. Human single-chain Fv antibodies to MUC1 core peptide selected from phage display libraries recognize unique epitopes and predominantly bind adenocarcinoma.
Henderikx P; Kandilogiannaki M; Petrarca C; von Mensdorff-Pouilly S; Hilgers JH; Krambovitis E; Arends JW; Hoogenboom HR
Cancer Res; 1998 Oct; 58(19):4324-32. PubMed ID: 9766660
[TBL] [Abstract][Full Text] [Related]
23. Radioimmunotherapy of MCF7 breast cancer cell line with 131I-PR81 monoclonal antibody against MUC1: comparison of direct and indirect radioiodination methods.
Mohammadnejad J; Rasaee MJ; Babaei MH; Paknejad M; Hasan ZM; Salouti M; Gandomkar M; Sadri K
Hum Antibodies; 2010; 19(1):15-25. PubMed ID: 20555127
[TBL] [Abstract][Full Text] [Related]
24. Enhanced natural killer cell binding and activation by low-fucose IgG1 antibody results in potent antibody-dependent cellular cytotoxicity induction at lower antigen density.
Niwa R; Sakurada M; Kobayashi Y; Uehara A; Matsushima K; Ueda R; Nakamura K; Shitara K
Clin Cancer Res; 2005 Mar; 11(6):2327-36. PubMed ID: 15788684
[TBL] [Abstract][Full Text] [Related]
25. Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1-specific CD8+ T cells identified by peptide-MHC-class-I tetramers.
Bohnenkamp HR; Coleman J; Burchell JM; Taylor-Papadimitriou J; Noll T
Cell Immunol; 2004; 231(1-2):112-25. PubMed ID: 15919376
[TBL] [Abstract][Full Text] [Related]
26. Expression of aberrantly glycosylated Mucin-1 in ovarian cancer.
Van Elssen CH; Frings PW; Bot FJ; Van de Vijver KK; Huls MB; Meek B; Hupperets P; Germeraad WT; Bos GM
Histopathology; 2010 Oct; 57(4):597-606. PubMed ID: 20955385
[TBL] [Abstract][Full Text] [Related]
27. Phase I dose escalation pharmacokinetic assessment of intravenous humanized anti-MUC1 antibody AS1402 in patients with advanced breast cancer.
Pegram MD; Borges VF; Ibrahim N; Fuloria J; Shapiro C; Perez S; Wang K; Schaedli Stark F; Courtenay Luck N
Breast Cancer Res; 2009; 11(5):R73. PubMed ID: 19811637
[TBL] [Abstract][Full Text] [Related]
28. Aberrantly glycosylated MUC1 is expressed on the surface of breast cancer cells and a target for antibody-dependent cell-mediated cytotoxicity.
Lavrsen K; Madsen CB; Rasch MG; Woetmann A; Ødum N; Mandel U; Clausen H; Pedersen AE; Wandall HH
Glycoconj J; 2013 Apr; 30(3):227-36. PubMed ID: 22878593
[TBL] [Abstract][Full Text] [Related]
29. GT-00AxIL15, a Novel Tumor-Targeted IL-15-Based Immunocytokine for the Treatment of TA-MUC1-Positive Solid Tumors: Preclinical In Vitro and In Vivo Pharmacodynamics and Biodistribution Studies.
Gellert J; Jäkel A; Danielczyk A; Goletz C; Lischke T; Flechner A; Dix L; Günzl A; Kehler P
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338686
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical detection of the MUC1 gene product in human cancers grown in scid mice.
Schumacher U; Adam E
J Histochem Cytochem; 1998 Jan; 46(1):127-34. PubMed ID: 9405502
[TBL] [Abstract][Full Text] [Related]
31. MUC1 protein expression in tumor cells regulates transcription of proinflammatory cytokines by forming a complex with nuclear factor-κB p65 and binding to cytokine promoters: importance of extracellular domain.
Cascio S; Zhang L; Finn OJ
J Biol Chem; 2011 Dec; 286(49):42248-42256. PubMed ID: 22021035
[TBL] [Abstract][Full Text] [Related]
32. A MUC1 mucin secreted from a colon carcinoma cell line inhibits target cell lysis by natural killer cells.
Zhang K; Sikut R; Hansson GC
Cell Immunol; 1997 Mar; 176(2):158-65. PubMed ID: 9073389
[TBL] [Abstract][Full Text] [Related]
33. Patterns of MUC1 tissue expression defined by an anti-MUC1 cytoplasmic tail monoclonal antibody in breast cancer.
Croce MV; Isla-Larrain MT; Rua CE; Rabassa ME; Gendler SJ; Segal-Eiras A
J Histochem Cytochem; 2003 Jun; 51(6):781-8. PubMed ID: 12754289
[TBL] [Abstract][Full Text] [Related]
34. Peritoneal fluid from ovarian cancer patients stimulates MUC1 epithelial mucin expression in ovarian cancer cell lines.
Munster DJ; Quin RJ; Bansal AS; Ward BG; McGuckin MA
Int J Cancer; 1998 May; 76(3):393-8. PubMed ID: 9579577
[TBL] [Abstract][Full Text] [Related]
35. Genetic variants of IgG1 antibodies and FcγRIIIa receptors influence the magnitude of antibody-dependent cell-mediated cytotoxicity against prostate cancer cells.
Pandey JP; Namboodiri AM
Oncoimmunology; 2014 Jan; 3(1):e27317. PubMed ID: 24701371
[TBL] [Abstract][Full Text] [Related]
36. Phosphorylation of the cytoplasmic domain of the MUC1 mucin correlates with changes in cell-cell adhesion.
Quin RJ; McGuckin MA
Int J Cancer; 2000 Aug; 87(4):499-506. PubMed ID: 10918188
[TBL] [Abstract][Full Text] [Related]
37. PankoMab: a potent new generation anti-tumour MUC1 antibody.
Danielczyk A; Stahn R; Faulstich D; Löffler A; Märten A; Karsten U; Goletz S
Cancer Immunol Immunother; 2006 Nov; 55(11):1337-47. PubMed ID: 16485130
[TBL] [Abstract][Full Text] [Related]
38. Heterogeneity in production, secretion and glycosylation of MUC1 epithelial mucin by primary cultures of ovarian carcinoma.
McGuckin MA; Hurst TG; Ward BG
Int J Cancer; 1995 Nov; 63(3):412-8. PubMed ID: 7591241
[TBL] [Abstract][Full Text] [Related]
39. Defucosylation of Tumor-Specific Humanized Anti-MUC1 Monoclonal Antibody Enhances NK Cell-Mediated Anti-Tumor Cell Cytotoxicity.
Gong Y; Klein Wolterink RGJ; Gulaia V; Cloosen S; Ehlers FAI; Wieten L; Graus YF; Bos GMJ; Germeraad WTV
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34070311
[TBL] [Abstract][Full Text] [Related]
40. Potential Interplay of the Gatipotuzumab Epitope TA-MUC1 and Estrogen Receptors in Ovarian Cancer.
Heublein S; Page S; Mayr D; Schmoeckel E; Trillsch F; Marmé F; Mahner S; Jeschke U; Vattai A
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30642093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
